Thus, the recent reports of reduced fucose and galactose saccharide residues in anti-SARS-CoV-2 IgG N-linked glycans isolated from patients with severe COVID-19 symptoms could be explained by a change in the ratio of IgG3 to IgG1 antibodies. The gene discussed is IGHG3; the disease is COVID-19.